Summary and take home messages from Parallel 2

European Bifurcation Club 2014, EBC 2014 - Bordeaux, France PARALLEL SESSIONS SYNOPSIS The Top 3 take home messages from the bifurcation quantitative analysis parallel session Author: Patrick Serruys, MD, PhD, Imperial College London, UK

Welcome to Bordeaux

European Bifurcation Club 2014, EBC 2014 - Bordeaux, France WELCOME TO BORDEAUX Author: Olivier Darremont, Clinique St. Augustin Bordeaux, France

Cross and Perfect Bifurcation Studies

European Bifurcation Club 2014, EBC 2014 - Bordeaux, France NEWS 2 SESSION Cross and Perfect Bifurcation Studies Author: Young-Hak Kim, MD, PhD, Heart Institute, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea

Systematic treatment of the side branch in a bifurcation lesion

European Bifurcation Club 2014, EBC 2014 - Bordeaux, France NEWS 2 SESSION Systematic treatment of the side branch in a bifurcation lesion with a new drug eluting balloon: the DEBSIDE study. Author: Jacques Berland, MD, Clinique Saint Hilaire, Rouen, France 

Potential Benefits of FKB

European Bifurcation Club 2014, EBC 2014 - Bordeaux, France NEWS 2 SESSION Potential Benefit of FKB After Single stent approach – Insights from OCT Author: Yoshinobu Murasato, MD, Kyushu Medical Center, Japan OBJECTIVE The aim of this study is to assess the impact of FKI on the stent strut apposition, neointimal coverage and thrombus attachment in the coronary bifurcation lesion 9 months after either EES or SES implantation using OCT. CONCLUSION FKI brought the following beneficial effects on the single stent approach in the bifurcation lesion. Enlarged lumen maintained in the proximal segment Homogeneous neointimal distribution Fewer jailed struts Fewer thrombus attachments Beneficial effect of FKI to achieve larger lumen in the proximal segment was weakened in DM patients probably due to more accelerated form of atherosclerosis.

Will Bioresorbable Scaffolds Change How We Think About Left Main PCI?

European Bifurcation Club 2014 - EBC 2014 - Bordeaux, France We can stent the Left Main trunk, but what is the best technique? Will Bioresorbable Scaffolds Change How We Think About Left Main PCI? Author: Robert-Jan van Geuns, MD, PhD, Professor of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands